On one side of the possible transaction, we have a suitor that is champing at the bit to spend its EUR12bn excess capital, and whose central strategy is to diversify globally and by product line via reinsurance business.
On one side of the possible transaction, we have a suitor that is champing at the bit to spend its EUR12bn excess capital, and whose central strategy is to diversify globally and by product line via reinsurance business.